What Doctors
Say
Please read what other medical professionals have to say regarding our important and revolutionary approach to Parkinson's disease care.

"Here is the important and revolutionary aspect of Dr. Hinz’s work: he has discovered a system that is able to keep the levels of all of the other brain chemicals in balance even when very high levels of L-dopa are used. This allows a complete resolution of symptoms."  

~ Frank Shallenberger, MD

View Article Here  Contact Us


"It was a couple landmark papers published in 2014 that really brought Dr. Hinz’s approach to Parkinson’s disease into the national spotlight… The end result, according to this research, was that carbidopa may contribute to the worsening of Parkinson’s disease and the increase in the Parkinson’s disease death rate seen since the introduction of these medications." 

~ Chad Oler, ND

View Article Here  Contact Us


"After evaluating laboratory results of hundreds of PD patients, Marty Hinz, a physician and medical director of NeuroResearch, found a way to properly manage the L-dopa side effects so that they do not limit access to the amount of L-dopa required to relieve symptoms." 

~ Dr. Roger N. Trubey, ND

View Article Here  Contact Us


"Once more, recent research conducted by Marty Hinz, MD has found that carbidopa induces a system-wide and catastrophic depletion in vitamin B6 by irreversibly binding to vitamin B6 and vitamin B6-dependent enzymes and permanently inactivating them (aromatic L-amino acid decarboxylase (AADC) is one of these enzymes). This induces a profound long-term vitamin B6 deficiency, resulting in an incredibly long list of side effects, as vitamin B6 impacts the function of over 300 enzymes and proteins in the body."  

~ Chad Oler, ND

View Article Here  Contact Us


"It is important to realize that unlike conventional L-dopa use, this approach needs to be implemented as early as possible in the management of Parkinson’s disease to attempt to halt progression and keep baseline function as high as possible. The approach Dr. Hinz developed is not directly treating Parkinson’s disease itself, but the profound nutritional deficiency that was not in place to protect the brain cells from the toxins in the first place." 

~ Dr. Roger N. Trubey, ND

View Article Here  Contact Us


"For the previous 5 years, I was engaged in a somewhat desperate search for a cure; or, at least an effective way to manage my symptoms which were intensifying monthly. My search took me into classical medical treatments, as well as to the lunatic fringe. I found Dr. Hinz’s approach to treating Parkinson’s both levelheaded and exciting." 

~ Barbara Roy - patient

View Article Here  Contact Us

"When care for Parkinson’s is required, without a doubt the best approach is the Hinz Protocol developed by Marty Hinz, MD." 

~ Beth McDougal, MD

View Article Here  Contact Us


"Thanks to Dr. Hinz’s efforts, we now have the tools to work with Parkinson’s Disease. Amino acid therapy counters the neurotransmitter imbalances of Parkinson’s effectively but without the additional negative side-effects." 

~ Carol Lourie, ND

View Article Here  Contact Us


"Dr. Hinz made the remarkable discovery that the side effects doctors see with high doses of l-dopa are not caused by l-dopa itself. They are caused by an imbalance in the other brain chemicals. It happens because when you increase the amount of one brain chemical you also affect the levels of the others." 

~ Frank Schallenberger, MD

View Website Here  Contact Us


"This approach is ahead of its time and when implemented by knowledgeable practitioner produces excellent results." 

~ Dr. Ross Stewart, Parkinson's Clinic International

View Website Here  Contact Us


"The mainstay of our approach to Parkinsonism involves amino acid balancing. This effective way of managing the symptoms and progression of Parkinson's was developed by Marty Hinz, M.D." 

~ Phil Ranheim, MD

View Article Here  Contact Us


"Marty Hinz, MD, of NeuroResearch Clinics Inc., and colleagues, note that during the first 15 years of prescribing L-dopa, the only known effective treatment for Parkinson's, a decreasing disease death rate was observed. Then, in 1976, 1 year after US Food and Drug Administration approved the original L-dopa/carbidopa combination drug, the Parkinson's disease death rate started increasing and has continued for 38 years and counting." 

~ (As published by Neurology Advisor)

View Article Here  Contact Us

Want to Learn More?

Are you a medical professional that wants to learn more? Are you currently receiving traditional Parkinson's disease care, and are interested in us contacting your doctor?  Contact us today!

Contact Us

Would you like more information on our unique approach to Parkinson's disease care?